Skip to main content
. 2003 Jul;41(7):2814–2821. doi: 10.1128/JCM.41.7.2814-2821.2003

TABLE 2.

Evaluation of NEVA HIV with HIV-1/2 combination performance panel with HIV-1- and HIV-2-infected samples from Boston Biomedica Inc.

Panel HIV type NEVA HIV resulta Titer byb:
WB HIV1/2 Diagnostic Biotechnology Ltd.c Dupont HIV antigen titer
Abbott HIV-1 GenSys HIV-2 GenSys HIV-1/2 Abbott HIV 1/2
PRZ202-01 2 POS 2.8 9.8 5.3 12.7 IND 0.0
PRZ202-02 1 POS >12.0 0.6 2.5 3.7 POS 0.2
PRZ202-03 2 POS 1.3 12.3 7.5 11.5 IND 0.0
PRZ202-04 NEGd NEG 0.3 0.2 0.1 0.4 NEG 0.0
PRZ202-05 2 POS 1.0 11.4 6.6 10.0 IND 0.1
PRZ202-06 1 POS >12.0 1.0 3.5 17.6 POS 0.1
PRZ202-07 1 POS >12.0 4.0 7.0 16.0 POS 0.0
PRZ202-08 2 POS 3.6 11.0 6.3 >17.9 IND 0.0
PRZ202-09 2 POS 5.7 11.6 6.4 7.6 POS 0.0
PRZ202-10 1 POS 0.5 0.1 0.2 7.6 NEG 14.4
PRZ202-11 1 POS 5.9 0.4 1.6 0.5 POS 0.0
PRZ202-12 2 POS 9.9 11.0 7.2 14.0 POS 0.0
PRZ202-13 1 POS 7.0 0.7 1.7 3.5 POS 2.3
PRZ202-14 2 POS >12.0 11.1 5.8 >17.9 IND 0.0
PRZ202-15 1 POS >12.0 12.0 8.4 >17.9 POS 0.0
a

See footnote b of Table 1.

b

See footnote c of Table 1.

c

See footnote e of Table 1.

d

NEG, negative.